Sep 30, 2013

United Therapeutics Q3 2013 Earnings Report

Total Revenue
$302M
Previous year: $243M
+24.6%
EPS
$2.98
Previous year: $1.46
+104.1%
Gross Profit
$272M
Previous year: $215M
+26.6%
Cash and Equivalents
$322M
Previous year: $263M
+22.3%
Total Assets
$1.93B
Previous year: $1.65B
+17.0%

United Therapeutics

United Therapeutics